Zhongzhi Pharmaceutical Holdings Limited
Zhongzhi Pharmaceutical Holdings Limited (3737) is a Hong Kong-based company engaged primarily in the research, development, manufacturing, and distribution of pharmaceutical products. The company operates in various sectors within the pharmaceutical industry, including traditional Chinese medicine, Western pharmaceuticals, and healthcare products. Zhongzhi focuses on creating innovative therapeutic solutions, with a portfolio that includes prescription medications, over-the-counter drugs, and dietary supplements aimed at improving health outcomes.